Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the effect of pregabalin in reducing the neuropathic pain in postoperative patients who have undergone single level Microdiscectomy for prolapsed intervetebral lumbar disc.


Clinical Trial Description

All patients were informed in detailed regarding the risk and complications and given written and informed consent, coming to our clinics were assessed by one of the senior team members of the spine, patient fulfilling the eligibility criteria were selected and included in the study. One week before the surgery the patients who met the eligibility criteria were randomized in a double-blind manner (participant and investigator) in a ratio of 1:1 into Group-A (Pregabalin 7mg, twice daily) or Group-B (Placebo, twice daily). The pain scores were recorded by VAS and Roland Morris score system on preoperative day compared to the scores on the 1st week postoperative follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04653792
Study type Interventional
Source Ziauddin University
Contact
Status Completed
Phase Phase 4
Start date June 4, 2018
Completion date April 17, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT06460194 - Treatment of Frostbite Sequelae With Botulinum Toxin A Phase 2
Recruiting NCT05009394 - Surgical Treatments for Postamputation Pain N/A
Not yet recruiting NCT06185816 - Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain Phase 2/Phase 3
Enrolling by invitation NCT03494842 - TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies N/A